World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

Login Register
World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

SJIF Impact Factor: 6.842

Abstract

PREPARATION AND EVALUATION OF TELMISARTAN SUSTAINED RELEASE TABLETS BY USING EUDRAGIT POLYMER

Inturi Ramya*, Dr. M. Dhanalakshmi and D. Ramchakradhar

ABSTRACT

The aim of the present study was to develop Telmisartan Sustained release tablets to maintain constant therapeutic levels of the drug for over 24 hrs. Eudragit RSPO, Eudragit RLPO were used as polymers. All the formulations were passed various physicochemical evaluation parameters such as bulk density, tapped density, carrs index, hausners ratio, angle of repose, weight variation, hardness, thickness, friability and drug content. From the dissolution studies it was evident that the formulation F10 showed better and desired drug release pattern i.e., 98.96 % in 12 hours. It contains the Eudragit RLPO as polymer. It followed Peppas release kinetics mechanism.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR